Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B

NCT03575208 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Slow/Insufficient accrual

Conditions

Chronic Hepatitis B

Interventions

BIOLOGICAL: hepatitis B immune globulin (HBIg)
DRUG: Pegylated interferon alfa (pegIFN)

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)